Search Results
Pharmaceutical Business eJournal

105,081 Total downloads | Link to this page | Subscribe to this eJournal (requires login)

Viewing: 1 - 50 of 785 papers

1.

Killer Acquisitions

Journal of Political Economy, Vol. 129, No. 3, pp. 649–702, March 2021
Number of pages: 97 Posted: 12 Sep 2018 Last Revised: 02 May 2021
Accepted Paper Series
London Business School, Yale School of Management and Yale School of Management
Downloads 8,885
2.

The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market

Number of pages: 67 Posted: 11 Jun 2008 Last Revised: 23 Feb 2014
Working Paper Series
Center for Entrepreneurship and Research Commercialization, Pratt School of Engineering, Cornell University - School of Industrial and Labor Relations, Duke University - Department of Sociology - Director, Center on Globalization, Governance & Competitiveness, Harvard University - Labor and Worklife Program and BusinessWeek
Downloads 2,941
3.

The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation

Washington University Journal of Law and Policy, Vol. 64, 2020
Number of pages: 22 Posted: 25 Jul 2020
Accepted Paper Series
Villanova University - Charles Widger School of Law
Downloads 2,202
4.

Unpatentable Drugs and the Standards of Patentability

Texas Law Review, Vol. 87, pp. 503-570, 2009
Number of pages: 68 Posted: 04 May 2008 Last Revised: 02 Jun 2013
Accepted Paper Series
affiliation not provided to SSRN
Downloads 2,003
5.

May Your Drug Price Be Evergreen

Oxford Journal of Law and the Biosciences (2018)
Number of pages: 58 Posted: 31 Oct 2017 Last Revised: 28 Apr 2019
Accepted Paper Series
UC Hastings Law
Downloads 1,757
6.

Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem

New York University Law Review, Vol. 81, p. 1553, 2006, Columbia Law and Economics Working Paper No. 306
Number of pages: 68 Posted: 21 Oct 2006 Last Revised: 28 Dec 2013
Accepted Paper Series
New York University School of Law
Downloads 1,715
7.

Machine Learning with Statistical Imputation for Predicting Drug Approvals

Number of pages: 60 Posted: 25 May 2017 Last Revised: 21 May 2019
Working Paper Series
Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering, Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering and Massachusetts Institute of Technology (MIT)
Downloads 1,307
8.

COVIDSafe, Australia’s Digital Contact Tracing App: The Legal Issues

Number of pages: 13 Posted: 03 May 2020
Working Paper Series
La Trobe Law School
Downloads 1,240
9.

Pharmaceutical Innovation

KSG Working Paper No. RWP07-004, AEI-Brookings Joint Center Working Paper No. 07-19
Number of pages: 59 Posted: 06 Feb 2007
Working Paper Series
Harvard University - Harvard Kennedy School (HKS)
Downloads 1,234
10.

AI on Drugs: Can Artificial Intelligence Accelerate Drug Development? Evidence from a Large-scale Examination of Bio-pharma Firms,

MISQ Forthcoming
Number of pages: 56 Posted: 20 Feb 2020 Last Revised: 06 Jun 2022
Accepted Paper Series
University of Connecticut - Operations & Information Management Department and University of Pennsylvania - The Wharton School
Downloads 1,228
11.

The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices

INCENTIVES FOR GLOBAL PUBLIC HEALTH: PATENT LAW AND ACCESS TO MEDICINES, Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (eds.), Cambridge: Cambridge University Press, 2010
Number of pages: 26 Posted: 09 Jul 2009
Accepted Paper Series
Yale Philosophy Department
Downloads 1,055
12.

The Indian Pharmaceutical Industry - an Overview of Internal Efficiencies Using Data Envelopment Analysis

Number of pages: 23 Posted: 11 May 2004
Working Paper Series
Indian Institute of Management (IIM), Calcutta and Indian Institute of Technology Kanpur
Downloads 1,047
13.

Drug Wars: A New Generation of Generic Pharmaceutical Delay

Harvard Journal on Legislation, Vol. 53, 2016, UC Hastings Research Paper No. 155
Number of pages: 64 Posted: 11 Sep 2015 Last Revised: 20 Jun 2016
Accepted Paper Series
UC Hastings Law and University of California Hastings College of the Law
Downloads 930
14.

The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic

Research Paper 116, South Centre, Geneva (August 2020), FSU College of Law, Public Law Research Paper No. 930, FSU College of Law, Law, Business & Economics Paper No. 20-16
Number of pages: 40 Posted: 28 Aug 2020
Working Paper Series
Florida State University - College of Law
Downloads 913
15.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents

Number of pages: 35 Posted: 16 Jul 2003
Working Paper Series
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Office of Health Economics
Downloads 884
16.

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

Number of pages: 38 Posted: 27 Sep 2006
Working Paper Series
University of Connecticut - Department of Finance and University of North Carolina (UNC) at Chapel Hill

Multiple version iconThere are 2 versions of this paper

Downloads 840
17.

Fundamental Analysis of Pharmaceutical Companies

Number of pages: 21 Posted: 16 Nov 2019
Working Paper Series
UCD Michael Smurfit Graduate Business School
Downloads 823
18.

Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002

Review of Economics and Statistics, Vol. 89, No. 3, 2007
Number of pages: 18 Posted: 28 Oct 2007 Last Revised: 08 Jun 2014
Accepted Paper Series
Downloads 819
19.

Global Drug Diffusion and Innovation with the Medicines Patent Pool

Number of pages: 96 Posted: 02 Aug 2019 Last Revised: 17 Dec 2021
Working Paper Series
University of Massachusetts Amherst - Department of Resource Economics

Multiple version iconThere are 2 versions of this paper

Downloads 743
20.

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

ISID Working Paper No. 2006/05
Number of pages: 68 Posted: 02 Dec 2009
Working Paper Series
Sardar Patel Institute of Economic & Social ResearchCentral University of Gujarat

Multiple version iconThere are 2 versions of this paper

Downloads 735
21.

The Invention of an Investment Incentive for Pharmaceutical Innovation

The Journal of World Intellectual Property (2012) Vol. 15, No. 5-6., pp. 1-60
Number of pages: 60 Posted: 20 Jan 2013 Last Revised: 19 Oct 2015
Accepted Paper Series
Nirma University - Institute of Law
Downloads 708
22.

Applications of Internet of Things in Pharmaceutical Industry

Number of pages: 14 Posted: 24 Aug 2019 Last Revised: 29 Aug 2019
Working Paper Series
University College of Engineering, Anna University - Bharathidasan Institute of Technology (BIT Campus), Anna University - Department of Pharmaceutical Technology and Anna University - Department of Pharmaceutical Technology

Multiple version iconThere are 2 versions of this paper

Downloads 705
23.

Patents on Psychedelics: The Next Legal Battlefront of Drug Development

135 Harvard Law Review Forum 212 (2022). , Harvard Public Law Working Paper No. 21-38
Number of pages: 24 Posted: 28 Oct 2021 Last Revised: 22 Feb 2022
Working Paper Series
Florida State University - College of Law and Harvard Law School
Downloads 654
24.

The COVID-19 Pandemic and the Challenge for Innovation Policy

Northern Ireland Legal Quarterly 71(1), 2020
Number of pages: 7 Posted: 15 Apr 2020 Last Revised: 29 Apr 2020
Accepted Paper Series
University of Melbourne - Law School and University of Bristol
Downloads 637
25.

Physician Agency and Adoption of Generic Pharmaceuticals

Number of pages: 52 Posted: 02 Jul 2011
Working Paper Series
University of Tokyo
Downloads 623
26.

Patent Amendment Act 2005: Its Effect on Indian Pharmaceutical Company

Number of pages: 14 Posted: 17 Jul 2009
Working Paper Series
West Bengal National University of Juridical Sciences
Downloads 608
27.

Accounting Profitability and the Political Process: The Case of R&D Accounting in the Pharmaceutical Industry

Number of pages: 52 Posted: 29 Nov 2014 Last Revised: 28 Jan 2020
Working Paper Series
Lancaster University - Department of Accounting and Finance, Heinrich Heine University Dusseldorf - Duesseldorf Institute for Competition Economics (DICE) and WHU - Otto Beisheim School of Management
Downloads 576
28.

Pharmaceutical Patent Enforcement: A Developmental Perspective

Number of pages: 33 Posted: 11 Dec 2014
Working Paper Series
Nirma University - Institute of Law, Independent and Independent
Downloads 565
29.

Bayesian Sequential Learning for Clinical Trials of Multiple Correlated Medical Interventions

INSEAD Working Paper No. 2020/40/TOM/ACGRE
Number of pages: 57 Posted: 25 May 2018 Last Revised: 02 Sep 2020
Working Paper Series
INSEAD - Technology and Operations Management, University of Pennsylvania - Operations & Information Management Department and Indiana University Bloomington - Kelley School of Business
Downloads 552
30.

Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda

Journal of Law, Medicine and Ethics, Vol. 14, No. 3, 2013, Forthcoming
Number of pages: 26 Posted: 11 Jul 2013
Accepted Paper Series
University of Texas - Pan AmericanHarvard University - Edmond J. Safra Center for Ethics
Downloads 542
31.

A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health

18 Yale J. L. & Tech. 275 (2016), Yale Law School, Public Law Research Paper No. 577, Yale Law & Economics Research Paper No. 560
Number of pages: 80 Posted: 03 Sep 2016 Last Revised: 21 Sep 2016
Accepted Paper Series
Hagens Berman Sobol Shapiro, Yale University - Law School, Independent and Yale University, Law School, Students
Downloads 538
32.

Perverse Incentives: Why Everyone Prefers High Drug Prices -- Except for Those Who Pay the Bills

57 Harv. J. on Legis. 303 (2020)
Number of pages: 74 Posted: 18 Apr 2018 Last Revised: 21 Oct 2020
Accepted Paper Series
UC Hastings Law
Downloads 538
33.

Legal Fallacies of Antipsychotic Drugs

Journal of the American Academy of Psychiatry and the Law, Vol. 35, p. 235, 2007
Number of pages: 12 Posted: 06 Dec 2006 Last Revised: 28 Mar 2008
Accepted Paper Series
Independent, University of Rochester Medical Center, University of Rochester, University of Rochester Medical Center and Mendota Mental Health Institute
Downloads 530
34.

Valuation of Intangible Assets: Estimating Late-Stage Development Cost of Pharmaceutical R&D

Number of pages: 52 Posted: 12 Sep 2007
Working Paper Series
Institute of Leadership and Management in Health - Kingston University and Henley Management College - Henley Centre for Value Improvement (HCVI)
Downloads 529
35.

The War on Drugs: Estimating the Effect of Prescription Drug Supply-Side Interventions

Number of pages: 78 Posted: 07 Mar 2016 Last Revised: 08 Sep 2016
Working Paper Series
Brown University - Department of Economics
Downloads 525
36.

Entry and Competition in Generic Biologics

Managerial and Decision Economics, 2007
Number of pages: 39 Posted: 17 Jul 2007 Last Revised: 20 Sep 2014
Accepted Paper Series
Duke University - Department of Economics, Duke University - Fuqua School of Business and Duke University - Medical Center
Downloads 491
37.

Fostering Production of Pharmaceutical Products in Developing Countries

Michigan Journal of International Law, Vol. 43, No. 1, 2021
Number of pages: 45 Posted: 19 Apr 2021
Accepted Paper Series
Harvard University - Berkman Klein Center for Internet & Society, Harvard Law School and Harvard University-Berkman Klein Center for Internet & Society
Downloads 479
38.

The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty

Quantitative Marketing and Economics, Vol.8, No. 2, pp.123-165, June 2010
Number of pages: 51 Posted: 29 Aug 2007 Last Revised: 06 Jul 2010
Accepted Paper Series
Johns Hopkins University - Carey Business School and New York University (NYU) - Leonard N. Stern School of Business
Downloads 478
39.

Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery

Yale Journal of Health Policy, Law, and Ethics, Vol. 8, No. 1, 2008
Number of pages: 37 Posted: 17 Jan 2008
Accepted Paper Series
Duke University School of Law, Duke University School of Law, The National Academies - National Academy of Sciences (NAS) and Independent
Downloads 472
40.

Curbing Unfair Drug Prices: A Primer for States

Global Health Justice Partnership Policy Paper, August 2017
Number of pages: 24 Posted: 27 Nov 2017
Accepted Paper Series
Yale School of Public Health, Yale University, Law School, Students, Yale University, Law School, Students, Yale University, Law School, Students and Yale School of Public Health
Downloads 466
41.

The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs

Published in Marketing Science 35(1):158-181, 2016, Rotman School of Management Working Paper No. 1782055
Number of pages: 54 Posted: 09 Mar 2011 Last Revised: 08 May 2020
Working Paper Series
Johns Hopkins University - Carey Business School, HEC Montreal, University of Toronto - Rotman School of ManagementUniversity of Toronto - Institute for Policy Analysis and York University
Downloads 466
42.

Why a COVID IP Waiver Is not a Good Strategy

Number of pages: 17 Posted: 11 May 2021
Working Paper Series
University of Copenhagen - Faculty of Law
Downloads 459
43.

The Effect of Debt to Asset Ratio, Return on Equity, and Current Ratio on Stock Prices of Pharmaceutical Companies Listed on the Indonesia Stock Exchange 2016-2019 Period

Journal of World Conference (JWC) 2021
Number of pages: 6 Posted: 15 Sep 2021
Accepted Paper Series
Universitas Bina Sarana Informatika, STMIK Dharmapala Riau and Universitas Pramita Indonesia
Downloads 450
44.

Mergers, Product Prices, and Innovation: Evidence from the Pharmaceutical Industry

Number of pages: 67 Posted: 07 Sep 2019 Last Revised: 12 Aug 2022
Working Paper Series
University of Arizona and Stevens Institute of Technology
Downloads 445
45.

Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic

Journal of International Economic Law (Oxford), Volume 23, Issue 3, pp. 535-561, Sept. 2020, FSU College of Law, Law, Business & Economics Paper No. 20-14, Duke Law School Public Law & Legal Theory Series No. 2020-46, FSU College of Law, Public Law Research Paper No. 927
Number of pages: 27 Posted: 25 Jul 2020 Last Revised: 17 Nov 2020
Working Paper Series
Florida State University - College of Law and Duke University School of Law
Downloads 435
46.

Solving the Challenges to World Trade

GWU Legal Studies Research Paper No. 2020-78, GWU Law School Public Law Research Paper No. 2020-78
Number of pages: 31 Posted: 23 Nov 2020
Accepted Paper Series
George Washington University - Law School
Downloads 435
47.

Pharmaceutical Patents in the TRIPS Agreement and the Right to Health: Can These Rights Be Reconciled?

University of Western Australia Law Review, Vol. 36, No. 1, 2012
Number of pages: 28 Posted: 07 Aug 2014
Accepted Paper Series
University of South Australia - School of Law
Downloads 434
48.

The Concept of an Agreement and Beyond: How to Block Parallel Imports of Pharmaceuticals to Protect the Heart of Competition

EC COMPETITION LAW A CRITICAL ASSESSMENT, Giuliano Amato, Claus-Dieter Ehlermann, eds., pp. 81-142, Hart Publishing, 2007
Number of pages: 62 Posted: 06 Dec 2007
Accepted Paper Series
European University Institute
Downloads 425
49.

Determinants of Licensing Decisions: A Study of Pharmaceutical Industry

In “Business, Economy and Environment: The New Normal”, Eds. Shamik Shome, Parag Rijwani and Deepak Danak, Himalaya Publishing House Pvt. Ltd., Mumbai for Institute of Management, Nirma University, Ahmedabad, Jan. 2019, ISBN 978-93-5299-653-7 pp. 242-258, This paper was presented at the 22nd Nirma International Conference on Management (NICOM 2019) on the theme of “Business, Economy and Environment: The New Normal” organized by the Institute of Management, Nirma University (IMNU), Ahmedabad, India during Jan. 17-19, 2019.
Number of pages: 17 Posted: 06 Mar 2019
Accepted Paper Series
Nirma University - Institute of Management and Nirma University - Institute of Management
Downloads 408
50.

Covid-19, Derechos de Propiedad Intelectual y Licencias Obligatorias (COVID-19, Intellectual Property Rights and Compulsory Licenses)

Revista Jurídica La Ley, Tomo 2020-C, 11 de junio de 2020 ISSN 0024-1636
Number of pages: 25 Posted: 24 Jun 2020
Working Paper Series
Universidad Austral - Facultad de Derecho and Universidad Austral - Facultad de Derecho
Downloads 406